68Ga-PSFA

N/A

Report date: 2025/09/19 17:44:57

Base Information

Drug Name68Ga-PSFA

Drug Alias Name68Ga-PSFA

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[4]

Mechanisms of ActionPositron-emission tomography enhancersProstate-Specific Membrane Antigen modulatorsFibroblast activation protein alpha modulators

TargetsProstate-Specific Membrane AntigenProlyl endopeptidase FAP

Therapy Area/IndicationsAdenomatous Polyposis Coli

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesFirst Affiliated Hospital Of Chongqing Medical University

China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Chongqing Medical University

Inactive CompaniesN/A

Active IndicationsAdenomatous Polyposis Coli

Inactive IndicationsN/A

Other Information

ATC CodeN/A